Delivery Order SPE2DB22D2206-SPE2DB25FJD70
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,178.58 to AmerisourceBergen Drug Corp for the supply of Potassium Chloride Extended Release 10 MEQ tablets in quantities of 1,000 units. This firm fixed-price delivery order, awarded on August 14, 2025, with an ultimate completion date of August 15, 2025, represents a routine pharmaceutical procurement from the vendor's Conshohocken, Pennsylvania location. The contract was competitively awarded with no set-aside...
- The Defense Logistics Agency awarded a delivery order valued at $3,133.24 to AmerisourceBergen Drug Corp for Potassium Chloride Extended Release 10 MEQ tablets (500-count packaging). This was a competitively awarded, firm fixed-price delivery order with no set-aside designation, completed on April 24, 2025. The pharmaceutical products will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters and primary...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Potassium Chloride Extended Release 10 MEQ tablets in quantities of 1,000 units, with a ceiling value of $5,993.44. This is a firm fixed price delivery order with an ultimate completion date of June 20, 2025, and represents a non-competitive set-aside award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $7,946.59 to AmerisourceBergen Drug Corp for the supply of Potassium Chloride Extended-Release 10 MEQ tablets in quantities of 1,000 units. This is a firm fixed price, non-set-aside contract with an ultimate completion date of July 18, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Potassium Chloride Extended Release 8 milliequivalent tablets in quantities of 500 units. This firm fixed price delivery order, valued at $6,588.65, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.9 billion prime vendor agreement supporting global pharmaceutical procurement for military...
- The Defense Logistics Agency awarded a delivery order valued at $4,137.79 to AmerisourceBergen Drug Corp for 1,000 tablets of Potassium Chloride Extended Release 10 MEQ. This is a firm fixed-price, competitively awarded contract with a completion date of September 12, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract carries no set-aside designation, reflecting open competition among qualified vendors. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Potassium Chloride Extended Release 20 MEQ tablets in quantities of 500, with a contract ceiling value of $4,934.88. This firm fixed-price delivery order, which has an ultimate completion date of August 15, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Potassium Chloride Extended Release 8 MEQ tablets in quantities of 500 units, with a contract ceiling value of $7,195.15. This is a firm fixed-price delivery order with an ultimate completion date of July 25, 2025, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as the place of performance for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Potassium Chloride Extended Release 10 milliequivalent tablets in quantities of 1,000 units, with a ceiling value of $1,326.38. This is a firm fixed-price delivery order with an ultimate completion date of July 15, 2025, and represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a $3,143.33 delivery order to AmerisourceBergen Drug Corp for the supply of Potassium Chloride Extended Release 10 milliequivalent tablets in quantities of 1,000 units. This is a firm fixed price, competitively awarded contract with an ultimate completion date of August 18, 2025. The contract will be performed at the contractor's location in Conshohocken, Pennsylvania. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's larger...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FJD70Delivery Order
The Defense Logistics Agency awarded a $3,179.24 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 1,000 tablets of Potassium Chloride Extended Release 10 MEQ on July 30, 2025, with a completion date of July 31, 2025. This non-set-aside contract represents a routine pharmaceutical procurement executed through the company's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion global pharmaceutical support vehicle running through December 2026. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs for military and veteran healthcare systems. As a child delivery order under the DLA's comprehensive pharmaceutical IDC, this award reflects the ongoing supply chain operations supporting military healthcare programs. AmerisourceBergen maintains significant federal pharmaceutical distribution capabilities, supplying generic and brand-name medications across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The potassium chloride procurement exemplifies the routine electrolyte and mineral supplementation products critical to military medical operations, demonstrating the vendor's role as a key supplier within the DLA's Troop Support Medical Supply Chain and its participation in the broader Pharmaceutical Prime Vendor Global Program.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 7/30/25 |